✦ LIBER ✦

Rapid Antibody Response after Vaccination with a Virosomal Hepatitis A Vaccine

✍ Scribed by F. Ambrosch; B. Finkel; C. Herzog; A. Koren; H. Kollaritsch

Book ID: 107705290
Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 252 KB
Volume: 32
Category: Article
ISSN: 0300-8126
DOI: 10.1007/s15010-004-3147-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicted 30-year protection after vacci

Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine

✍ Patrick A. Bovier; Jürgen Bock; Tiziana Farinelli Ebengo; Gert Frösner; Jacqueli 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

## Abstract Few studies have examined the duration of protection following vaccination against hepatitis A virus (HAV) with currently licensed HAV vaccines. This study explored the long‐term immunogenicity in individuals vaccinated with the virosomal hepatitis A virus, Epaxal®. Adult volunteers (N

Long-term immunogenicity of an inactivat

Long-term immunogenicity of an inactivated virosome hepatitis A vaccine

✍ P.A. Bovier; J. Bock; L. Loutan; T. Farinelli; R. Glueck; C. Herzog 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract The aim of this study was to predict the long‐term protection induced after immunisation with inactivated, aluminium‐free virosome hepatitis A vaccine. The study population consisted of adult volunteers enrolled in four different clinical trials. Lower 95% confidence interval limits and

Mathematical models for assessment of lo

Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines

✍ Van Herck, K.; Beutels, P.; Van Damme, P.; Beutels, M.; Van den Dries, J.; Brian 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Very few studies with inactivated hepatitis A vaccines were designed for long-term follow-up of antibody persistence. Based on the serological data from these vaccine trials, mathematical models were developed to predict the decrease of anti-hepatitis A virus (anti-HAV) antibodies after vaccination.

Urinary antibody response after immunisa

Urinary antibody response after immunisation with a vaccine against urinary tract infection

✍ Kruze, D. ;Holzbecher, K. ;Andrial, M. ;Bossart, W. 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 450 KB

Neutralising Antibody Response to Oral P

Neutralising Antibody Response to Oral Poliovirus Vaccine after Primary Immunisation with Inactivated Poliovirus Vaccine

✍ N. Guérin; P. Bregère; P. Caudrelier; O. Raynaud 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 30 KB

Characterization of a human monoclonal a

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine

✍ R.A. Heijtink; J. Kruining; P. van Bergen; S. de Rave; J. van Hattum; M. Schutte 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

A human monoclonal antibody type IgG4, designated 1Ff4, was obtained by Epstein Barr virus transformation of peripheral blood lymphocytes from a hepatitis B vaccinee (HB-VAX: plasmaderived vaccine) after one boost of yeast recombinant DNA derived vaccine (Engerix-B). 1Ff4 binds preferentially to HBs